Skip to main content
About
Contact
Subscribe
e-Edition
Make Home Page
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Twitter
Toggle navigation
Site search
Search
Home
Contact Us
Advertise
Subscription Services
Promote Your Event
Submission Forms
News
Local News
National
World
Archives
Sports
Local Sports
National Sports
Business
Local Business
National Business
Technology
Markets & Stocks
Opinion
Columns
Editorials
Letters To The Editor
Polls
Thumbs
A & E
Local Entertainment
Art Scene
Music Scene
Theatre Scene
Book Reviews
Movie Reviews
TV Listings
Local Events
What To Do
Life
Health
Travel
Oddities
Community Directory
Community Service
Rescue Me
Other
Specials
Spring Home & Garden Show
Home & Realty
Outdoor Guide
Women
Spring on the Road
Spring Wellness
Premier Home Stylle Tour 2024
Classifieds
Place Ad
Careers
Tenders
Weather
Obituaries
Parcel Pickup
2024 Readersâ Choice
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Anixa Biosciences Inc
(NQ:
ANIX
)
3.160
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, Oct 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
26
Open
3.160
Bid (Size)
3.010 (2)
Ask (Size)
3.160 (20)
Prev. Close
3.160
Today's Range
3.160 - 3.160
52wk Range
2.145 - 5.130
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Anixa Biosciences And 3 Other Stocks Under $5 Insiders Are Buying
July 29, 2024
Via
Benzinga
EXCLUSIVE: FDA Approves Anixa Biosciences' Individual Patient Trial Application For Ovarian Cancer CAR-T Therapy
July 23, 2024
FDA Approves Anixa Biosciences' Ovarian Cancer CAR-T Therapy for Individual Patient Trial. Moffit Cancer Center receives approval for a second dose in an ongoing Phase I trial showing early promising...
Via
Benzinga
Exposures
Product Safety
Performance
YTD
-19.59%
-19.59%
1 Month
-2.17%
-2.17%
3 Month
+14.08%
+14.08%
6 Month
-0.63%
-0.63%
1 Year
+2.60%
+2.60%
More News
Read More
EXCLUSIVE: Anixa Biosciences Finds Stock Undervalued, Launches $5M Stock Buyback Program
July 15, 2024
Via
Benzinga
ANIX Stock Earnings: Anixa Biosciences Beats EPS for Q2 2024
June 04, 2024
Via
InvestorPlace
7 Penny Biotech Stocks to Triple Your Investment
May 28, 2024
Via
InvestorPlace
Recap: Anixa Biosciences Q1 Earnings
March 12, 2024
Via
Benzinga
6 Analysts Have This to Say About Anixa Biosciences
June 19, 2023
Via
Benzinga
The Latest Analyst Ratings for Anixa Biosciences
May 23, 2023
Via
Benzinga
Expert Ratings for Anixa Biosciences
April 18, 2023
Via
Benzinga
Anixa Biosciences, Inc. (NASDAQ: ANIX) Featured in Coverage of the EF Hutton Annual Global Conference
May 16, 2024
Via
Investor Brand Network
Sidoti Events, LLC's Virtual May Micro-Cap Conference
May 07, 2024
Via
ACCESSWIRE
Anixa Biosciences (NASDAQ:ANIX) Gains Attention for Its Innovative Cancer Therapies Amid Biopharma Sector Growth
March 20, 2024
Via
AB Newswire
Sidoti Events, LLC's Virtual January Micro-Cap Conference
January 15, 2024
Via
ACCESSWIRE
Anixa Biosciences, A New Type Of Biotech Company: Could It Disrupt The Cancer Landscape?
December 20, 2023
Via
Benzinga
3 Biotech Stocks to Turn $5,000 Into $1 Million: December 2023
December 11, 2023
Via
InvestorPlace
Anixa Biosciences Reveals Updated Data From Breast Cancer Vaccine Trial, Says 'Exceeded Expectations'
December 07, 2023
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
December 07, 2023
Via
Benzinga
The 3 Most Undervalued Cheap Stocks to Buy in September 2023
September 11, 2023
Via
InvestorPlace
Could Anixa Biosciences (NASDAQ:ANIX) Be Developing The Vaccine To End One Of The Deadliest Types Of Breast Cancer?
August 10, 2023
Via
ACCESSWIRE
Could Anixa Biosciences (NASDAQ: ANIX) Be Developing The Vaccine To End One Of The Deadliest Types Of Breast Cancer?
August 09, 2023
Via
Benzinga
Anixa Biosciences And 2 Other Penny Stocks Insiders Are Aggressively Buying
July 24, 2023
Via
Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
February 23, 2023
Via
Benzinga
Appreciating The Passing Of A Titan & Incorporating Alternative Data Signals
December 27, 2022
Via
Talk Markets
Benzinga's Top Ratings Upgrades, Downgrades For December 23, 2022
December 23, 2022
Via
Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
December 09, 2022
Via
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.